Hospice Compliance Warnings Ignored: The Warning Reached Management and the Billing Continued

Hospice compliance officer fraud reporting connects an internal warning to the people who received it, the response they chose and the Medicare claims that followed. You may know exactly when an audit identified ineligible patients, who received the findings and why billing continued. That sequence can put a hospice whistleblower case inside the company’s own compliance files.

What a Hospice Compliance Program Is Supposed to Catch

A hospice compliance program connects written policies, a responsible officer, training, complaint handling, audits, discipline and corrective action across the health care operation. In its 1999 hospice compliance guidance, the Department of Health and Human Services Office of Inspector General described those seven elements as a voluntary framework. The work produces records: what staff learned, what they reported, what reviewers found and what management did about it.

The concerns reach across the business. An admission review examines the clinical basis for eligibility and recertification. A care review compares the patient’s needs and interdisciplinary group plan with the services actually delivered. A billing review connects that care to the claim: routine home care, continuous home care, inpatient respite care or general inpatient care. The guidance called for documenting plan reviews and updates, and checking whether the billed level matched the care needed. Marketing and facility arrangements raise their own questions about payments for patient referrals.

The Inspector General’s guidance called for retaining training attendance logs and the materials distributed. It also described complaint logs that record the investigation and its results, with that information reported to leadership. A signed training sheet, an unanswered clinical concern and a later claim tell different parts of the story. The useful comparison is what the hospice taught staff to do against what happened when someone raised a problem.

In the Caris settlement announcement, the Justice Department emphasized examining how widespread a compliance problem was and identifying prior overpayments. That makes the review after the finding part of the evidence.

When Hospice Eligibility Warnings Reach Management

When a hospice compliance officer’s eligibility warnings were ignored, the evidence turns on who received the clinical findings and what happened to the affected claims. Caris Healthcare shows the sequence in concrete terms.

Caris agreed to an $8.5 million settlement in June 2018. The government alleged that the hospice chain admitted and recertified ineligible patients to meet aggressive admissions and census targets. Patients’ medical records did not support a terminal prognosis, according to the government’s account.

DOJ described warnings from inside the company: internal audits, concerns from the chief medical officer and recommendations from nurses who examined patients. The government alleged that Caris continued billing and took no meaningful action to identify earlier overpayments after those warnings.

The whistleblower’s complaint supplies a view of how the clinical record itself allegedly changed:

Improvement was information the certification process needed. The nurse alleged that she was told to leave it out. Together with the government’s account of ignored audits and clinical recommendations, that allegation makes the inquiry specific: what did the patient show, what reached the physician and what reached the people responsible for billing?

Caris also shows why a functioning review matters to a whistleblower case. The government alleged that the company had generated findings that called eligibility into question and kept submitting claims anyway. In that account, the audit had found the problem. The response was the problem that followed.

When Management Refused Action on Hospice Compliance Audit Findings

The response to hospice compliance audit findings shows what management knew before the next claim. We examine the warning as a sequence: the clinical problem, the recipient, the decision and the billing afterward.

An audit finding, the message escalating it and the claims submitted afterward connect management’s response to the billing. A repayment analysis addresses payments already received.

Curo Health Services supplies a parallel. In its June 2021 complaint announcement, the Justice Department described alleged pressure at Tennessee hospice agencies to increase admissions and census while discouraging discharge of patients who were no longer eligible. The government also alleged that certifying physicians did not receive or adequately consider complete and accurate information about patients’ conditions.

According to that announcement, internal complaints and audits alerted the defendants that they had billed Medicare or Medicaid for ineligible patients. The government alleged that they failed to return the payments. The warning concerned both continued enrollment and money already received.

The allegations about Curo’s Tennessee operations became part of the broader Gentiva settlement announced in July 2024. The executed agreement set the settlement at $19,428,570, covering the Tennessee allegations and additional conduct elsewhere. The original eligibility decision, later billing and retention of earlier payments each supplied a different part of the case.

When Training and Oversight Reach the Patient Chart

Guardian Hospice shows how training and oversight allegations can connect to the information used to certify patients. In its October 2015 settlement announcement, DOJ said Guardian agreed to pay $3 million over allegations that it knowingly billed Medicare for patients who were not terminally ill.

The government described inadequate eligibility training for staff and medical directors, aggressive recruitment and enrollment targets, and inadequate oversight of the Atlanta hospice. Those practices allegedly contributed to claims for patients without a terminal prognosis of six months or less.

The former employees’ complaint alleged that warnings reached a certifying physician:

That allegation connects the warning to the person using the questioned information. It gives the training and oversight concerns a practical focus: what information staff challenged and which certifications followed.

How Board Escalation Changes the Evidence

Board escalation shows how far a warning reached inside the company. The Inspector General’s guidance recommended that the compliance officer have direct access to the chief executive and board.

It also recommended reporting paths outside the normal chain of command so supervisors could not divert reports. Audit findings were to reach senior management, including the parent company’s leadership where a larger business owned the hospice.

For an insider, the question becomes concrete. Did the board receive the finding that patients lacked support for eligibility, or did the report stop below it? Did the response address those patients and their claims? Board materials, escalation emails and follow-up reviews can connect the finding to the response at another level of the company.

The same guidance called for evaluating whether compliance activities actually occurred and for checking whether corrective measures worked. A revised policy and the claims submitted afterward can be compared. The response has to be visible in the operation if it is to explain what changed.

Why the Daily Payment Belongs Beside the Warning

Medicare’s routine hospice payment follows enrolled days, while the work and costs vary across the stay. Costs tend to be higher around admission and death and lower in between. That gives an eligibility or discharge warning a financial consequence: keeping the patient enrolled keeps the daily payment coming.

The Inspector General’s 2015 study, Medicare Hospices Have Financial Incentives to Provide Care in Assisted Living Facilities, examined Medicare hospice claims from 2007 through 2012. It found longer care and higher payments for beneficiaries in assisted living than in other settings. The daily payment kept coming even when visits took up little of the week:

For a compliance review, the useful comparison puts the visit record, the patient’s needs, the eligibility assessment and the payment together. A census target measures patients kept on service. A clinical assessment asks whether those patients belong there. The Caris and Curo allegations show what can happen when management’s response favors the target after clinicians raise the eligibility question.

Care quality also needs its own examination. The Inspector General’s 2019 report on hospice deficiencies found that common deficiencies included poor care planning, mismanagement of aide services and inadequate patient assessments. Taxpayers fund the benefit, and patients bear the consequences when the care falls short. Our review connects the care and clinical information to the particular claim.

What Evidence Is Needed to Prove Fraud?

The strongest evidence of healthcare fraud connects an identified patient, the clinical information or service at issue, the claim dates and the people who knew about the problem. Connecting those pieces is work we do with you.

Different roles see different parts of that connection. Compliance and finance staff may see the warning, the escalation and the repayment analysis.

We follow the finding into the decisions that affected Medicare payment. Your knowledge of the operation can put hospice fraud inside the company’s own decision-making. If your own role in the compliance review raises questions, that is another reason to speak with us.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

Your Warning Deserves a Response

If your hospice kept billing after you raised an eligibility concern or delivered an audit finding, speak with our whistleblower experts about what management knew. We work beside you to turn that knowledge into your strongest hospice whistleblower case and bring in hospice fraud whistleblower lawyers who understand clinical records and Medicare billing. We stay with you from the first conversation through the case.